Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial
- Resource Type
- Article
- Source
- In
Clinical Breast Cancer October 2016 16(5):349-355 - Subject
- Language
- ISSN
- 1526-8209